Topiramate: a review of preclinical, pharmacokinetic, and clinical data (Q32135911)

6 July 2017

1 reference

title

Topiramate: a review of preclinical, pharmacokinetic, and clinical data (English)

1 reference

6 July 2017

1 reference

W E Rosenfeld

1

1 reference

6 July 2017

1 November 1997

1 reference

6 July 2017

Clinical Therapeutics

1 reference

6 July 2017

19

1 reference

6 July 2017

1294-1308

1 reference

6 July 2017

6

1 reference

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Newer antiepileptic drugs. Towards an improved risk-benefit ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Comparative pharmacokinetics of the newer antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

An investigation into the mechanical and transport properties of aqueous latex films: a new hypothesis for the film-forming mechanism of aqueous dispersion system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980006-9

7 January 2021

10.1016/S0149-2918(97)80006-9

Identifiers

DOI

1 reference

6 July 2017

1 reference

PubMed ID

9444441